"Arming" the chimeric oncolytic adenovirus enadenotucirev to deliver checkpoint inhibitors and other therapeutics directly to tumours

Por Champion, Brian R, Kodialbail, Prithvi, Illingworth, Sam, Rasiah, Nalini, Cochrane, Dan, Beadle, John, Fisher, Kerry, Brown, Alice CN
Publicado no J Immunother Cancer (2014)